| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000046645 |
| Receipt No. | R000053186 |
| Scientific Title | Study of the effect of improving wrinkles at the corners of the eyes by using skin care cosmetics |
| Date of disclosure of the study information | 2022/01/15 |
| Last modified on | 2022/07/08 (Ver. 4) |
| Basic information | ||
| Public title | Study of the effect of improving wrinkles at the corners of the eyes by using Asakado skin care cosmetics | |
| Acronym | Study of the effect of improving wrinkles at the corners of the eyes by using Asakado skin care cosmetics | |
| Scientific Title | Study of the effect of improving wrinkles at the corners of the eyes by using skin care cosmetics | |
| Scientific Title:Acronym | Study of the effect of improving wrinkles at the corners of the eyes by using skin care cosmetics | |
| Region |
|
|
| Condition | ||
| Condition | Healthy volunteer | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To verify the effect of skin care cosmetics on improving wrinkles at the corners of the eyes |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | evaluation of wrinkles(JCSS) |
| Key secondary outcomes | Skin elasticity evaluation, evaluation by questionnaire |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | No treatment |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | apply test cosmetics | |
| Interventions/Control_2 | Do not apply test cosmetics | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Female | |||
| Key inclusion criteria | [1]Japanese females aged 35-54 years
[2]Individuals who do not have chronic physical illnesses, including skin disorders [3]Individuals whose wrinkles at the corners of the eyes are judged to be wrinkle great 1-3 [4]Individuals who have wrinkles at the corners of the eyes that are almost symmetrical [5]Individuals whose written informed consent has been obtained [6]Individuals who can come to the designated examination date and receive the examination [7]Individuals judged appropriate for the study by the principal |
|||
| Key exclusion criteria | Individuals (who)
[1]using medical products [2]under treatment or with history of mental disorders, sleep disorders, hypertension, diabetes, lipid metabolism abnormality, or other serious disorders [3]with history of serious diseases (hepatic, renal, cardiovascular, respiratory, hematologic, etc.) [4]have a history and/or contract digestive disease [5]with a history of cosmetic troubles or current medical history [6]with skin symptoms such as atopic dermatitis, perioral dermatitis, and rosacea-like dermatitis [7]with experience in cosmetology and aesthetic medicine that affect the measuring area [8]have performed or received the following acts within the past 3 months a.Hormone replacement therapy b.Use of cosmetics (eye cream, sealer, patch, etc.) that have strong moisturizing effect and wrinkle-related effect c.Regular use of medicines, quasi-drugs, foods and drinks for the purpose of improving the skin [9]have an inflammation or a scar on a measuring area [10]receiving/received medical drug treatment for the past 1 month except for temporary relief medication for headache, menstrual pain, common cold, etc. [11]drink more than 60g/day on average in terms of pure alcohol [12]with possible changes of life style during test periods [13]will develop seasonal allergy symptoms, such as pollinosis, use an anti-allergic drug [14]can't avoid direct sunlight exposure, such as sunburn, during test periods. [15]are or are possibly pregnant, or are breastfeeding [16]are participating and/or had participated in other clinical studies within the last 3 months [17]are judged as not appropriate to this study by a responsible doctor |
|||
| Target sample size | 34 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Faculty of Life and Medical Sciences,Doshisha University | ||||||
| Division name | Anti-Aging Medical Research Center | ||||||
| Zip code | 6100394 | ||||||
| Address | 1-3 Tatara Miyakodani,Kyotanabe City,Kyoto | ||||||
| TEL | 0774-65-6394 | ||||||
| yyonei@mail.doshisha.ac.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | TES Holdings Co., Ltd. | ||||||
| Division name | Department of Clinical Trial | ||||||
| Zip code | 1100015 | ||||||
| Address | 6F,Kairaku Bldg,2-7-5 Higashi-Ueno,Taitou-ku,Tokyo | ||||||
| TEL | 03-6801-8400 | ||||||
| Homepage URL | |||||||
| info@tes-h.co.jp | |||||||
| Sponsor | |
| Institute | Anti-Aging Bank Co.,Ltd. |
| Institute | |
| Department | |
| Funding Source | |
| Organization | NABOCULcosmetics.co.,ltd |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Society of Glycative Stress Research |
| Address | 5F-11,Musashino Bldg,2-13-10 Shinjuku,Shinjuku-ku,Tokyo |
| Tel | 03-6709-8842 |
| rinri-glycativestress@antiaging-bank.com | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | うえのあさがおクリニック(東京都) |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | 34 |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000053186 |